Facilitating Motor Skill Learning in Parkinson’s Disease

Overview

The study is designed to assess the effects of aerobic exercise on motor learning in Parkinson patients. Specifically, the investigators examine whether a single bout of moderate intensity aerobic exercise, performed immediately before task practice, facilitates the acquisition and retention of a motor skill. In a cross-over design, participants will be randomly allocated to either the intervention group (aerobic exercise before motor learning) or control group (rest before motor learning).

Full Title of Study: “Facilitating Motor Skill Learning by Aerobic Training in Parkinson’s Disease”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Crossover Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: May 31, 2018

Detailed Description

Parkinson's disease is a progressive neurodegenerative disorder that is characterized by motor control impairments, such as gait disturbances and postural instability. Beneficial effects of exercise are attributed to mechanisms of neuroplasticity, and task-specific motor training is consequently considered to be a motor learning process. While motor learning is preserved in persons with Parkinson's disease, slower acquisition rates and reduced retention have been reported compared to healthy individuals. Thus, it is crucial to identify strategies to enhance motor learning in people with Parkinson's disease. Recent studies have accumulated evidence to show that aerobic exercise can facilitate motor skill learning. However, these observations are limited to healthy individuals and have not been addressed in individuals with neurologic conditions. The present study is designed to assess the effects of a single bout of moderate intensity aerobic exercise on a motor skill learning task in patients with Parkinson's disease. In a cross-over design, participants will be randomly allocated to one of two groups. Both groups will practice balancing on a specific stability platform (motor learning task). The experimental group will additionally perform a bout of aerobic exercise (cycle ergometer) immediately before the motor learning task, while the control group will rest before practice. Subsequently, the acquisition and one-day retention of the motor learning task will be examined.

Interventions

  • Behavioral: aerobic exercise
    • Single-bout of moderate intensity aerobic exercise on a cycle ergometer before motor learning
  • Behavioral: rest
    • Seated rest before motor learning
  • Behavioral: motor learning
    • Motor learning task on a stability platform (Stabilometer). Participants try to keep the tiltable platform in an horizontal position.

Arms, Groups and Cohorts

  • Experimental: aerobic exercise + motor skill practice
    • acute bout of aerobic exercise before motor learning
  • Active Comparator: rest + motor skill practice
    • seated rest before motor learning

Clinical Trial Outcome Measures

Primary Measures

  • Motor Learning (Precision)
    • Time Frame: Baseline (first trial of practice day 1), 1 day (last trial of practice day 1), and 7 days (first trial of 7-day retention session).
    • Change from baseline in time in balance (±5° from horizontal) during balancing task.

Secondary Measures

  • Motor Learning (Variability)
    • Time Frame: Baseline (first trial of practice day 1), 1 day (last trial of practice day 1), and 7 days (first trial of 7-day retention session).
    • Change from baseline in mean standard deviation (root mean square error) of platform deflection (in degree).

Participating in This Clinical Trial

Inclusion Criteria

  • Parkinson's disease stage 1-3 on Hoehn & Yahr scale – Ability to stand unaided and walk without an assistive device – Stable medication during the study period Exclusion Criteria:

  • On-off and wearing-off phenomena – Unstable medical or psychiatric illness – Clinically relevant cardiovascular or orthopaedic disease – Severe polyneuropathy – Cognitive impairment – Smoking > 10 cigarettes/day – Caffeine > 6 cups of coffee/day – Alcohol > 50 g (two glasses)/day

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University of Erlangen-Nürnberg
  • Collaborator
    • German Foundation for Neurology
  • Provider of Information About this Clinical Study
    • Principal Investigator: Simon Steib, PhD, Dr. – University of Erlangen-Nürnberg
  • Overall Official(s)
    • Simon Steib, Dr., Principal Investigator, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Institute of Sport Science and Sport

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.